4.5 Review

European Society of Gynaecological Oncology Guidelines for the Management of Patients With Vulvar Cancer

Journal

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
Volume 27, Issue 4, Pages 832-837

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/IGC.0000000000000975

Keywords

Algorithms; Guidelines; Quality indicators; Vulvar cancer

Funding

  1. Institut National du Cancer (INCa, France)

Ask authors/readers for more resources

Objective The aim of this study was to develop clinically relevant and evidence-based guidelines as part of European Society of Gynaecological Oncology's mission to improve the quality of care for women with gynecologic cancers across Europe. Methods The European Society of Gynaecological Oncology Council nominated an international development group made of practicing clinicians who provide care to patients with vulvar cancer and have demonstrated leadership and interest in the management of patients with vulvar cancer (18 experts across Europe). To ensure that the statements are evidence based, the current literature identified from a systematic search has been reviewed and critically appraised. In the absence of any clear scientific evidence, judgment was based on the professional experience and consensus of the development group (expert agreement). The guidelines are thus based on the best available evidence and expert agreement. Prior to publication, the guidelines were reviewed by 181 international reviewers including patient representatives independent from the development group. Results The guidelines cover diagnosis and referral, preoperative investigations, surgical management (local treatment, groin treatment including sentinel lymph node procedure, reconstructive surgery), radiation therapy, chemoradiation, systemic treatment, treatment of recurrent disease (vulvar recurrence, groin recurrence, distant metastases), and follow-up.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Pathology

CXCR4/ACKR3/CXCL12 axis in the lymphatic metastasis of vulvar squamous cell carcinoma

Natalia Rusetska, Kamil Kowalski, Kamil Zalewski, Sebastian Zieba, Mariusz Bidzinski, Krzysztof Goryca, Beata Kotowicz, Malgorzata Fuksiewicz, Janusz Kopczynski, Elwira Bakula-Zalewska, Artur Kowalik, Magdalena Kowalewska

Summary: The study found that the CXCR4/ACKR3/CXCL12 axis is activated during progression and lymphatic spread of VSCC. CXCR4 and ACKR3 proteins are nearly absent in precancerous lesions but are strong in VSCC samples. Additionally, serum CXCL12 levels are significantly increased in both patients with VSCC and premalignant vulvar lesions.

JOURNAL OF CLINICAL PATHOLOGY (2022)

Article Obstetrics & Gynecology

Open vs minimally invasive radical trachelectomy in early-stage cervical cancer: International Radical Trachelectomy Assessment Study

Gloria Salvo, Pedro T. Ramirez, Mario M. Leitao, David Cibula, Xiaohua Wu, Henrik Falconer, Jan Persson, Myriam Perrotta, Berit J. Mosgaard, Ali Kucukmetin, Igor Berlev, Gabriel Rendon, Kaijiang Liu, Marcelo Vieira, Mihai E. Capilna, Christina Fotopoulou, Glauco Baiocchi, Dilyara Kaidarova, Reitan Ribeiro, Silvana Pedra-Nobre, Roman Kocian, Xiaoqi Li, Jin Li, Kolbrun Palsdottir, Florencia Noll, Stuart Rundle, Elena Ulrikh, Zhijun Hu, Mihai Gheorghe, Srdjan Saso, Raikhan Bolatbekova, Audrey Tsunoda, Brandelyn Pitcher, Jimin Wu, Diana Urbauer, Rene Pareja

Summary: The 4.5-year disease-free survival rates did not differ between open radical trachelectomy and minimally invasive radical trachelectomy, with low recurrence rates in both groups. Ongoing prospective studies may help guide future management of early-stage cervical cancer.

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2022)

Article Obstetrics & Gynecology

The prognostic value of the number of positive lymph nodes and the lymph node ratio in early-stage cervical cancer

Ester P. Olthof, Constantijne H. Mom, Malou L. H. Snijders, Hans H. B. Wenzel, Jacobus Velden, Maaike A. Aa

Summary: The number of lymph node metastases and the lymph node ratio have an impact on survival in patients with early-stage cervical cancer. Categorizing patients based on lymph node status can help determine their risk of survival.

ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA (2022)

Article Oncology

Treatment of bulky lymph nodes in locally advanced cervical cancer: boosting versus debulking

Ester Paulien Olthof, Hans Wenzel, Jacobus van der Velden, Anje M. Spijkerboer, Ruud Bekkers, Jogchum J. Beltman, Hans W. Nijman, Brigitte Slangen, Ramon Smolders, Nienke van Trommel, Petra L. M. Zusterzeel, Ronald Zweemer, Lukas J. A. Stalpers, Maaike van der Aa, Constantijne Mom

Summary: This study found no survival benefit from either nodal boosting or debulking strategy in patients with suspicious bulky nodes. Nodal boosting might, however, be associated with less toxicity.

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2022)

Review Medicine, General & Internal

The Polish Society of Gynecological Oncology Guidelines for the Diagnosis and Treatment of Endometrial Carcinoma (2023)

Jacek J. Sznurkowski, Janusz Rys, Artur Kowalik, Agnieszka Zolciak-Siwinska, Lubomir Bodnar, Anita Chudecka-Glaz, Pawel Blecharz, Aleksandra Zielinska, Andrzej Marszalek, Mariusz Bidzinski, Wlodzimierz Sawicki

Summary: Due to the heterogeneous nature of endometrial carcinoma, the Polish Society of Gynecological Oncology (PSGO) has developed new guidelines to summarize the current evidence for diagnosis, treatment, and follow-up of the disease and to provide evidence-based recommendations for clinical practice.

JOURNAL OF CLINICAL MEDICINE (2023)

Article Oncology

Twenty years of experience with less radical fertility-sparing surgery in early-stage cervical cancer: Pregnancy outcomes

Helena Robova, Lukas Rob, Michael J. Halaska, Jana Drozenova, Tomas Pichlik, Vit Drochytek, Martin Hruda

Summary: This study presents the results of fertility-sparing surgery in cervical cancer patients, showing a promising pregnancy rate of 82.9% and delivery rate of 76.2%.

GYNECOLOGIC ONCOLOGY (2023)

Article Oncology

Randomized Phase III Study Comparing Neoadjuvant Chemotherapy Followed by Surgery Versus Chemoradiation in Stage IB2-IIB Cervical Cancer: EORTC-55994

Gemma G. Kenter, Stefano Greggi, Ignace Vergote, Dionyssios Katsaros, Juliusz Kobierski, Heleen van Doorn, Fabio Landoni, Jacobus van der Velden, Nicholas Reed, Corneel Coens, Iske van Luijk, Nicoletta Colombo, Elzbietta van der Steen-Banasik, Nelleke Ottevanger, Antonio Casado

Summary: This trial compared the efficacy of neoadjuvant chemotherapy followed by surgery with concomitant chemoradiation in patients with stage Ib2-IIB cervical cancer. The results showed no significant difference in the 5-year overall survival rate between the two treatment arms.

JOURNAL OF CLINICAL ONCOLOGY (2023)

Article Virology

Accuracy of Human Papillomavirus (HPV) Testing on Urine and Vaginal Self-Samples Compared to Clinician-Collected Cervical Sample in Women Referred to Colposcopy

Marianna Martinelli, Chiara Giubbi, Maria Letizia Di Meo, Federica Perdoni, Rosario Musumeci, Biagio Eugenio Leone, Robert Fruscio, Fabio Landoni, Clementina Elvezia Cocuzza

Summary: This study evaluated the accuracy of HPV testing using self-collected urine and vaginal samples, comparing them to physician-collected cervical swabs. The results showed significant concordance in high-risk HPV detection between self-collected samples and clinical counterparts. The study highlights the efficacy of self-sampling in detecting high-grade cervical lesions and emphasizes its role in increasing participation.

VIRUSES-BASEL (2023)

Review Oncology

Reproductive Results in Cancer Survivors after Fertility Sparing Management: The Need for the Standardization of Definitions

Szymon Piatek, Iwona Szymusik, Mariusz Bidzinski

Summary: The definition of reproductive outcomes after fertility-sparing management (FSM) is not standardized and different terms and criteria are used. It is unclear whether pregnancy or childbirth rates should be the primary endpoints, and the evaluation of pregnancy/birth rates is confusing due to the selection of different reference groups. Moreover, discussing the chances of childbearing with patients is complicated. Therefore, uniform definitions of reproductive outcomes should be established.

CANCERS (2023)

Article Oncology

Obstetric Results after Fertility-Sparing Management of Non-Epithelial Ovarian Cancer

Szymon Piatek, Iwona Szymusik, Piotr Sobiczewski, Wojciech Michalski, Magdalena Kowalska, Mariusz Oltarzewski, Mariusz Bidzinski

Summary: This study aimed to evaluate the recurrence and birth rates among patients with non-epithelial ovarian cancer. A total of 146 patients who underwent fertility-sparing surgery for germ cell (GCT) and sex cord-stromal tumors (SCST) were included. The 5- and 10-year disease-free survival rates were 91% and 83%, respectively. After a 24-month follow-up, the recurrence rate was higher than the rate of childbearing, but after 2 years, the childbearing rates exceeded the rate of recurrence.

CANCERS (2023)

Article Oncology

Selective Removal of Only Clinically Suspicious Positive Lymph Nodes Instead of a Complete Inguino-Femoral Lymph Node Dissection in Squamous Cell Carcinoma of the Vulva

Guus Fons, Nikki B. Thuijs, Ming Tjiong, Lukas J. A. Stalpers, Jacobus van der Velden

Summary: For patients with evidence of vulvar tumor spread to the lymph nodes in the groin, current treatment involves removal of the primary tumor and all regional lymph nodes followed by radiotherapy. This study explored an alternative treatment method involving selective removal of enlarged lymph nodes only, followed by radiotherapy. The study found that there was no difference in survival rates between the group treated with selective removal and the group treated with complete lymph node removal.

CANCERS (2023)

Article Oncology

The risk of lymph node metastasis in the new FIGO 2018 stage IA cervical cancer with >7 mm diameter

Laure Nicolai, Refika Yigit, Maaike C. G. Bleeker, Joost Bart, Jacobus van der Velden, Constantijne H. Mom

Summary: For patients with stage IA cervical cancer with a diameter >7 mm, we recommend considering a pelvic lymph node assessment in case of DOI >3 mm and/or presence of LVSI.

JOURNAL OF GYNECOLOGIC ONCOLOGY (2023)

Meeting Abstract Oncology

INTEGRATED MOLECULAR PROFILE OF PLATINUM RESISTANT EPITHELIAL OVARIAN CARCINOMA

Karolina Seborova, Viktor Hlavac, Petr Holy, Sunniva Bjorklund, Thomas Fleischer, Alzbeta Spalenkova, Lukas Rob, Martin Hruda, Petr Cernaj, Jiri Bouda, Vessela N. Kristensen, Pavel Soucek, Radka Vaclavikova

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2022)

Meeting Abstract Oncology

TWENTY YEARS OF EXPERIENCE WITH LESS RADICAL FERTILITY-SPARING SURGERY IN EARLY-STAGE CERVICAL CANCER

Martin Hruda, Helena Robova, Lukas Rob, Michael Jiri Halaska, Jana Drozenova, Tomas Pichlik, Hana Malikova

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2022)

Review Health Care Sciences & Services

Hyaluronic Acid: A Valid Therapeutic Option for Early Management of Genitourinary Syndrome of Menopause in Cancer Survivors?

Rossella E. Nappi, Silvia Martella, Francesca Albani, Chiara Cassani, Ellis Martini, Fabio Landoni

Summary: Genitourinary syndrome of menopause (GSM) is a chronic condition that affects women's urogenital health and sexual function. Symptoms are often not reported or underestimated, leading to underdiagnosis and undertreatment. Local estrogen therapy is the mainstay of vaginal treatments, but it may not be suitable for women with a history of hormone receptor positive cancer. Hyaluronic acid-based moisturizers may be a safe and effective non-hormonal treatment option, especially for women with a history of cancer.

HEALTHCARE (2022)

No Data Available